Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non Operating Income: 2012-2024

Historic Other Non Operating Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $4.1 million.

  • Amphastar Pharmaceuticals' Other Non Operating Income rose 104.53% to $231,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 156.44%. This contributed to the annual value of $4.1 million for FY2024, which is 203.74% up from last year.
  • Amphastar Pharmaceuticals' Other Non Operating Income amounted to $4.1 million in FY2024, which was up 203.74% from -$3.9 million recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income ranged from a high of $14.5 million in FY2021 and a low of -$6.6 million during FY2020.
  • Moreover, its 3-year median value for Other Non Operating Income was $4.1 million (2024), whereas its average is $3.1 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Other Non Operating Income soared by 320.74% in 2021, and later slumped by 143.33% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other Non Operating Income (Yearly) stood at -$6.6 million in 2020, then soared by 320.74% to $14.5 million in 2021, then crashed by 37.62% to $9.1 million in 2022, then crashed by 143.33% to -$3.9 million in 2023, then skyrocketed by 203.74% to $4.1 million in 2024.